EVAN CONRAD: Open Payments
NPI 1013547736 · MESQUITE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,047 in 35 payments from 17 companies in 2025. Trend: 2023 $841 · 2024 $504 · 2025 $1,047
Food & beverage: $1,047
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 6 | $258 |
| Janssen Biotech, Inc. | 3 | $183 |
| Dendreon Pharmaceuticals LLC | 3 | $85 |
| PFIZER INC. | 3 | $75 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $67 |
| TOLMAR, INC. | 3 | $53 |
| Ferring Pharmaceuticals Inc. | 2 | $51 |
| Azurity Pharmaceuticals, Inc. | 2 | $43 |
| Endo USA, Inc. | 2 | $42 |
| Medtronic, Inc. | 1 | $37 |
Products named: ORGOVYX, ERLEADA, XTANDI, PROVENGE, Nubeqa, ADSTILADRIN, AZMIRO, JATENZO.
Industry payments across TX — which companies pay providers there.
